Factors Moving Markets - Research Report on Medivation, Inc., Dendreon Corporation, True Religion Apparel, Inc., V.F.

    Factors Moving Markets - Research Report on Medivation, Inc., Dendreon
Corporation, True Religion Apparel, Inc., V.F. Corporation and Electronic Arts
                                     Inc.

PR Newswire

NEW YORK, February 25, 2013

NEW YORK, February 25, 2013 /PRNewswire/ --

Today, National Traders Association announced new research reports
highlighting Medivation, Inc. (NASDAQ: MDVN), Dendreon Corporation (NASDAQ:
DNDN), True Religion Apparel, Inc. (NASDAQ: TRLG), V.F. Corporation (NYSE:
VFC) and Electronic Arts Inc. (NASDQ: EA). Today's readers may access these
reports free of charge - including full price targets, industry analysis and
analyst ratings - via the links below.

Medivation, Inc. Research Report

Xtandi has been well-received by the market. Astellas, Medivation's partner,
had earlier provided Xtandi's net sales guidance of $100 million for the
fiscal year ending Mar 31, 2013, but now expects its sales to reach even
higher. More details about enzulatamide research will be presented by Atellas
and Medivation on February 14. The company is optimistic about the
possibilities of Xtandi, including a study that will allow patients who have
not undergone chemotherapy to use the drug, and also a study that allows
Xtandi for breast cancer (Phase I). The Full Research Report on Medivation,
Inc. - including full detailed breakdown, analyst ratings and price targets -
is available to download free of charge at:
[http://www.Investors-Alliance.com/r/full_research_report/67e4_MDVN]

--

Dendreon Corporation Research Report

The company is seeking approval to sell Provenge in Europe, allowing it to
expand its market. The final decision will be made in the middle of this year.
Closer to home, more doctors are starting to prescribe Provenge because it
works by training the immune system to target cancer cells as opposed to other
drugs that make use of other agents to fight cancer. Furthermore, Dendreon
presently has six drugs on Phase II and III statuses. These drugs include one
that can treat prostate cancer patients who have not undergone chemotherapy as
well as a new drug that targets cancer cells present in the bladder, ovary,
prostate and the breasts. The Full Research Report on Dendreon Corporation -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.Investors-Alliance.com/r/full_research_report/402d_DNDN]

--

True Religion Apparel, Inc. Research Report

After almost a year of constant struggle, True Religion Apparel Inc. was still
able to close 2012 with positive Q4 results, proving all the negative
projections wrong, and starting to turn heads once again. Analysts said that
the company's Q4 was an impressive bounce-back after its two-year lag. This
recovery is highly attributed to the company's improving capability to
generate consistent cash flows despite the pangs of economic recession.
Moreover, the fashion industry in the global setting continues to improve,
fueled by creative advertising, pop culture and endorsements from famous
personalities. The Full Research Report on True Religion Apparel, Inc. -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.Investors-Alliance.com/r/full_research_report/1013_TRLG]

--

V.F. Corporation Research Report

More and more investors are eyeing the company not just because of its current
trading performance. It's also because of its impressive ability for expansive
growth while offering large dividends. At first glance, the current
performance of True Religion and VF shows that the apparel industry is on a
steady rise despite the tough economic climate. Both companies offer their
products for a premium which has turned their clothing lines into status
symbols. The common ground between True Religion Apparel and VF is the quality
which has so far been consistent. The signs are looking good for both
companies and their peers as the US economy is slowly recovering, but won't
take off by the second half of 2013. True Religion Apparel should focus more
on keeping their numbers up to earn back the full trust of their stakeholders.
This will help the company grow and be more capable of sustaining its global
operations. The same is also true for VF, in order for the company to retain
their leadership in the fashion scene. The Full Research Report on V.F.
Corporation - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:
[http://www.Investors-Alliance.com/r/full_research_report/d0b7_VFC]

--

Electronic Arts Inc. Research Report

A good portion of steady growth stem from FIFA sales, which sold over 12
million units over the fiscal quarter. As the market continues to shift to
mobile gadgets, EA may need to further their research and development for
cutting edge mobile platforms as both companies continue to create new games
that will engage their markets. While EA is considered the #1 worldwide
publisher on iOS for the year, uncertainties towards iPhones and iPads may be
an area of concern. However, EA seems to be acting fast as it recently
partnered with Samsung to develop the Korean electronic company's game
library. EA may also improve its run rate with the help of Dead Space 3 which
is considered one of the best games of this generation. The Full Research
Report on Electronic Arts Inc. - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:
[http://www.Investors-Alliance.com/r/full_research_report/1414_EA]

--

Consider Investors-Alliance

Tired of hearing about the latest, greatest trade opportunity... only to
realize that the ship has long sailed? You need a strong, informative
community in your arsenal. Join the group that has been consistently
identifying momentous situations as they develop - long before they become the
next top news on major financial networks.

Contact: Patricia Byers
Email: press@Investors-Alliance.com
Main: +1-480-745-7826

SOURCE Investors-Alliance
 
Press spacebar to pause and continue. Press esc to stop.